Yan Cai Selected Research

Feitai

1/2005	Effect of Feitai on bleomycin-induced pulmonary fibrosis in rats.
5/2004	Feitai attenuates bleomycin-induced pulmonary fibrosis in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan Cai Research Topics

Disease

62	Neoplasms (Cancer) 01/2022 - 01/2002
15	Esophageal Squamous Cell Carcinoma 04/2022 - 01/2007
15	Inflammation (Inflammations) 11/2021 - 05/2006
14	Vascular Calcification 01/2019 - 08/2009
12	Infections 01/2022 - 12/2013
12	Fibrosis (Cirrhosis) 10/2019 - 05/2004
11	Amyloid Plaque 01/2017 - 12/2009
10	Alzheimer Disease (Alzheimer's Disease) 05/2022 - 02/2010
10	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2020 - 01/2002
9	Carcinogenesis 01/2019 - 09/2002
8	Body Weight (Weight, Body) 01/2022 - 02/2003
8	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2015 - 05/2004
7	Pre-Eclampsia (Preeclampsia) 10/2021 - 12/2016
6	Dementia (Dementias) 05/2022 - 10/2010
6	Critical Illness (Critically Ill) 01/2022 - 11/2011
6	Stroke (Strokes) 06/2018 - 01/2012
6	Esophageal Neoplasms (Esophageal Cancer) 01/2018 - 09/2002
5	Carcinoma (Carcinomatosis) 01/2022 - 09/2002
5	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 02/2013
5	Atherosclerosis 01/2021 - 10/2012
5	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2007
4	Hemorrhage 11/2021 - 05/2008
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 01/2012
4	Obesity 01/2021 - 02/2003
4	Atherosclerotic Plaque (Atheroma) 02/2019 - 03/2010
4	Choroidal Neovascularization 06/2014 - 08/2010
4	Multiple Organ Failure (MODS) 04/2014 - 08/2004
3	Sepsis (Septicemia) 01/2022 - 07/2010
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2017
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 03/2014
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 02/2016
3	Wounds and Injuries (Trauma) 11/2019 - 04/2019
3	Fatty Liver 03/2018 - 10/2015
3	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 04/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 07/2012
3	Insulin Resistance 01/2017 - 02/2003
3	Lung Injury 03/2015 - 05/2004
3	Pneumonia (Pneumonitis) 01/2014 - 08/2004
3	Hypertrophy 07/2010 - 08/2006
3	Myocardial Infarction 11/2009 - 04/2008
2	Neonatal Sepsis 01/2022 - 01/2022
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2021
2	COVID-19 11/2021 - 09/2021
2	Glioma (Gliomas) 02/2021 - 01/2021
2	Nasopharyngeal Carcinoma 01/2021 - 06/2015
2	Ovarian Epithelial Carcinoma 01/2021 - 01/2014
2	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2021 - 11/2017

Drug/Important Bio-Agent (IBA)

47	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2002
21	Messenger RNA (mRNA)IBA 04/2022 - 09/2002
13	Biomarkers (Surrogate Marker)IBA 09/2021 - 03/2009
10	Pharmaceutical PreparationsIBA 06/2020 - 08/2007
10	Amyloid (Amyloid Fibrils)IBA 01/2019 - 12/2009
9	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 02/2003
8	Bleomycin (Blenoxane)FDA LinkGeneric 07/2015 - 05/2004
7	Ethanol (Ethyl Alcohol)IBA 01/2020 - 10/2015
7	CytokinesIBA 11/2018 - 05/2006
6	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2009
6	CollagenIBA 10/2019 - 05/2006
5	LipidsIBA 11/2021 - 06/2018
5	Indicators and Reagents (Reagents)IBA 01/2021 - 04/2002
5	MicroRNAs (MicroRNA)IBA 01/2020 - 03/2013
5	Insulin (Novolin)FDA Link 01/2020 - 02/2003
4	Peptides (Polypeptides)IBA 12/2021 - 10/2010
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2021 - 12/2002
4	Apolipoproteins E (ApoE)IBA 01/2021 - 10/2012
4	Biological ProductsIBA 01/2021 - 10/2015
4	CalciumIBA 08/2018 - 08/2009
4	Malondialdehyde (Propanedial)IBA 06/2018 - 01/2005
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2006
4	Phosphates (Orthophosphate)IBA 10/2015 - 05/2011
4	Hydroxyproline (4 Hydroxyproline)IBA 07/2015 - 01/2005
4	SecretoglobinsIBA 07/2015 - 01/2014
3	oxidized low density lipoproteinIBA 01/2021 - 02/2014
3	Uric Acid (Urate)IBA 11/2020 - 03/2014
3	Lipocalin-2IBA 01/2020 - 01/2016
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2018 - 07/2011
3	EnzymesIBA 06/2018 - 01/2007
3	AntioxidantsIBA 06/2018 - 05/2004
3	Blood Glucose (Blood Sugar)IBA 01/2018 - 01/2013
3	Superoxide DismutaseIBA 01/2017 - 12/2007
3	Caspase 3 (Caspase-3)IBA 01/2017 - 09/2009
3	Interleukin-8 (Interleukin 8)IBA 01/2017 - 11/2016
3	Protein Isoforms (Isoforms)IBA 04/2011 - 09/2002
3	Nicotine FDA Link 04/2010 - 08/2009
3	Cholecalciferol (Vitamin D3)FDA Link 04/2010 - 08/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2022 - 04/2019
2	Vancomycin FDA LinkGeneric 01/2022 - 04/2019
2	Long Noncoding RNAIBA 01/2022 - 10/2021
2	Monoclonal AntibodiesIBA 12/2021 - 11/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 09/2021 - 01/2014
2	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 01/2014
2	6-methyladenineIBA 01/2021 - 01/2020
2	PlatinumIBA 01/2021 - 01/2014

Therapy/Procedure

19	Therapeutics 11/2021 - 08/2004
5	Artificial Respiration (Mechanical Ventilation) 01/2022 - 11/2011
5	Drug Therapy (Chemotherapy) 09/2021 - 01/2013
4	Lasers (Laser) 01/2016 - 08/2007
3	Continuous Renal Replacement Therapy 04/2014 - 11/2011
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 09/2021
2	Radiotherapy 02/2021 - 01/2021